WS #13301
AstraZeneca in talks to acquire Bristol Myers Squibb in a near-$400bn deal, creating world's fourth-largest drugmaker.
AstraZeneca-BMS Merger Talks
AstraZeneca in talks to acquire Bristol Myers Squibb in a near-$400bn deal, creating world's fourth-largest drugmaker.